Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer.

Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD.

J Clin Oncol. 2004 Jul 1;22(13):2532-9.

PMID:
15226321
2.
3.

Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.

Berry W, Eisenberger M.

Oncologist. 2005;10 Suppl 3:30-9. Review.

4.

Future directions in the treatment of androgen-independent prostate cancer.

Petrylak DP.

Urology. 2005 Jun;65(6 Suppl):8-12. Review.

PMID:
15939077
5.

The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer.

McKeage MJ.

Expert Opin Investig Drugs. 2008 Jan;17(1):23-9. Review.

PMID:
18095916
6.

The evolving role of docetaxel in the management of androgen independent prostate cancer.

Khan MA, Carducci M, Partin AW.

J Urol. 2003 Nov;170(5):1709-16. Review.

PMID:
14532760
7.

[Promising new treatment options for metastatic androgen-independent prostate cancer].

Tan W.

Actas Urol Esp. 2007 Jun;31(6):680-5. Review. Spanish.

PMID:
17896565
8.

Chemotherapy for prostate cancer: finally an advance!

Gulley J, Dahut WL.

Am J Ther. 2004 Jul-Aug;11(4):288-94. Review.

PMID:
15266221
9.

Shifting paradigms in prostate cancer; docetaxel plus low-dose prednisone - finally an effective chemotherapy.

de Wit R.

Eur J Cancer. 2005 Mar;41(4):502-7. Epub 2005 Jan 26. Review.

PMID:
15737553
10.

[Prostate cancer: update].

Oudard S, Medioni J, Scotté F, Banu E.

Bull Cancer. 2005 Oct;92(10):865-73. Review. French.

11.

Optimal timing of chemotherapy in androgen independent prostate cancer.

Schnadig ID, Beer TM.

Urol Oncol. 2009 Jan-Feb;27(1):97-100. doi: 10.1016/j.urolonc.2008.04.004. Review.

PMID:
19111808
12.

Development of weekly high-dose calcitriol based therapy for prostate cancer.

Beer TM.

Urol Oncol. 2003 Sep-Oct;21(5):399-405. Review.

PMID:
14670552

Supplemental Content

Support Center